AISAP

Point-of-Care Assisted Diagnosis

Health Tech & Life Sciences
Private
Follow

Company Overview

Snapshot

Founded in January 2022 by Adiel Am-Shalom and Ehud Raanani, AISAP operates with 11–50 employees. The company has secured funding across two rounds from two investors. In August 2024, AISAP received FDA approval for its cardiac ultrasound software platform.

Business overview

AISAP develops AI-powered point-of-care ultrasound solutions for clinicians, focusing on real-time acquisition guidance, immediate interpretation, and multi-organ diagnoses. Its core product, POCAD, is an intuitive, secure cloud-based platform that provides AI-powered ultrasound diagnosis anywhere, connecting care teams for efficient treatment at the patient's bedside. The company serves the healthcare industry, operating within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Digital Medical Diagnostics, leveraging artificial intelligence and deep learning for medical imaging and diagnostics.

Strategic signal

In November 2025, AISAP launched a landmark field initiative in Ghana, deploying its FDA-cleared AI Point-of-Care Diagnostics technology to address rural health challenges. This initiative demonstrates the company's commitment to expanding access to advanced diagnostic tools in underserved regions and provides a blueprint for addressing similar cardiology deserts in other markets, signaling a significant strategic move towards global market penetration and impact.

Log in to access full profile

Company Intelligence Q&A

What is AISAP's core technology?
AISAP's core technology is POCAD, a deep-learning, secure, cloud-based platform that provides real-time analysis of images and data from any ultrasound device, assesses patient conditions, and predicts patient outcomes.
When did AISAP receive FDA clearance for its cardiac ultrasound software?
AISAP's CARDIO AI-powered Point-of-Care Ultrasound Diagnostic Software received FDA clearance in August 2024.
Which investors participated in AISAP's May 2024 funding round?
In May 2024, AISAP received funding from Shoni Health Ventures and Harel Insurance & Finance.
What recognition did AISAP receive in March 2025?
In March 2025, AISAP was named to Fast Company’s List of the World’s Most Innovative Companies of 2025.
How is AISAP's technology being used in military applications?
In November 2023, AISAP's AI-powered ultrasound solution was used to assist in the treatment of wounded soldiers, providing military doctors in the field with immediate interpretation of cardiac ultrasound scans directly to mobile phones.
Log in to access full profile